HSY
31
-6
AN
50
-5
EW
32
3
LEN
50
-2
CINF
53
3
EXPD
43
-4
HCA
48
-2
CMS
60
2
DTE
43
5
CVX
43
-3
KEY
43
-3
XYL
35
-2
GOOGL
48
-5
COP
57
-2
CCI
30
-11
AME
74
-4
UAL
83
-2
TMO
42
-6
CI
45
-3
EOG
56
-2
HSY
31
-6
AN
50
-5
EW
32
3
LEN
50
-2
CINF
53
3
EXPD
43
-4
HCA
48
-2
CMS
60
2
DTE
43
5
CVX
43
-3
KEY
43
-3
XYL
35
-2
GOOGL
48
-5
COP
57
-2
CCI
30
-11
AME
74
-4
UAL
83
-2
TMO
42
-6
CI
45
-3
EOG
56
-2
Financhill
Back

Brookfield Renewable Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
48

BEPC.TO
Brookfield Renewable

Last Price:
42.39
Seasonality Move:
-3.17%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
48
Brookfield Renewable (BEPC.TO) is a Sell

Is Brookfield Renewable a Buy, Sell or Hold?

  • The current Brookfield Renewable [BEPC.TO] share price is $42.39. The Score for BEPC.TO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • BEPC.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BEPC.TO Stock Price Chart

What is Brookfield Renewable's stock price today?

  • The Brookfield Renewable share price today is $42.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BEPC.TO is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

BEPC.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 47.3 Sell
Chaikin Money Flow: -126653 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.51 - 45.81) Sell
Bollinger Bands (100): (38.36 - 43.38) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

BEPC.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.35 Buy
20-day SMA: 43.88 Sell
50-day SMA: 42.57 Sell
200-day SMA: 38.59 Buy
8-day EMA: 42.53 Sell
20-day EMA: 42.98 Sell
50-day EMA: 42.47 Sell
200-day EMA: 40.04 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Brookfield Renewable Earnings Growth & BEPC.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.99 per share, and a decrease next year of $0.80 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Brookfield Renewable Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):